SEC
SlamSEC
SearchBrowseEarnings

Nanobiotix S.A.

Nasdaq:NBTX
Pharmaceutical Preparations·PARIS, I0
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(273 total)

TypeDateAccessionPeriodSize
6-K
Mar 12, 2026
0001171843-26-001529FORM 6-K
Mar 12, 2026
13.2 KB
6-K
Feb 25, 2026
0001171843-26-001103FORM 6-K
Feb 25, 2026
10.9 KB
6-K
Dec 17, 2025
0001171843-25-007983FORM 6-K
Dec 17, 2025
13.6 KB
6-K
Dec 15, 2025
0001171843-25-007931FORM 6-K
Dec 15, 2025
13.4 KB
6-K
Dec 1, 2025
0001628280-25-0544806-K
Dec 1, 2025
313.5 KB
6-K
Nov 24, 2025
0001171843-25-007543FORM 6-K
Nov 24, 2025
21.0 KB
6-K
Nov 14, 2025
0001171843-25-007331FORM 6-K
Nov 13, 2025
18.6 KB
6-K
Nov 14, 2025
0001171843-25-007306FORM 6-K
Nov 14, 2025
13.3 KB
6-K
Nov 12, 2025
0001171843-25-007215FORM 6-K
Nov 11, 2025
10.5 KB
6-K
Nov 3, 2025
0001171843-25-006906FORM 6-K
Nov 3, 2025
11.0 KB
6-K
Oct 31, 2025
0001171843-25-006848FORM 6-K
Oct 31, 2025
19.7 KB
6-K
Oct 24, 2025
0001171843-25-006647FORM 6-K
Oct 24, 2025
15.3 KB
6-K
Oct 15, 2025
0001171843-25-006427FORM 6-K
Oct 15, 2025
13.4 KB
6-K
Oct 1, 2025
0001171843-25-006226FORM 6-K
Oct 1, 2025
21.0 KB
6-K
Sep 30, 2025
0001628280-25-0432326-K
Jun 30, 2025
10.9 MB
6-K
Sep 30, 2025
0001171843-25-006189FORM 6-K
Sep 30, 2025
19.6 KB
6-K
Sep 30, 2025
0001171843-25-006152FORM 6-K
Sep 29, 2025
22.9 KB
6-K
Sep 17, 2025
0001171843-25-005941FORM 6-K
Sep 17, 2025
20.7 KB
6-K
Sep 12, 2025
0001171843-25-005887FORM 6-K
Sep 12, 2025
12.4 KB
6-K
Sep 2, 2025
0001171843-25-005677FORM 6-K
Sep 2, 2025
10.5 KB
6-K
Aug 27, 2025
0001171843-25-005609FORM 6-K
Aug 27, 2025
13.4 KB
6-K
Jul 11, 2025
0001171843-25-004438FORM 6-K
Jul 7, 2025
16.0 KB
6-K
Jul 2, 2025
0001628280-25-0338446-K
Jul 2, 2025
1.0 MB
6-K
Jun 10, 2025
0001171843-25-003816FORM 6-K
Jun 10, 2025
13.2 KB
6-K
May 28, 2025
0001171843-25-003475FORM 6-K
May 28, 2025
10.3 KB
25 filings shown

Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts.